16 October 2000 in The EMBO Journal
13 September 2011 in Cytoskeleton
10 April 2003 in Oncogene
1 July 2005 in Journal of Biological Chemistry
The caspase-8 inhibitor c-FLIP exists as two splice variants, c-FLIPL and c-FLIPS, with distinct roles in death receptor signaling. The mechanisms determining their turnover have not been established. We found that in differentiating K562 erythroleukemia cells both c-FLIP isoforms were inducibly degraded by the proteasome, but c-FLIPS was more prone to ubiquitylation and had a considerably shorter half-life. Analysis of the c-FLIPS-specific ubiquitylation revealed two lysines, 192 and 195, C-terminal to the death effector domains, as principal ubiquitin acceptors in c-FLIPS but not in c-FLIPL. Furthermore the c-FLIPS-specific tail of 19 amino acids, adjacent to the two target lysines, was demonstrated to be the key element determining the isoform-specific instability of c-FLIPS. Molecular modeling in combination with site-directed mutagenesis demonstrated that the C-terminal tail is required for correct positioning and subsequent ubiquitylation of the target lysines. Because the antiapoptotic operation of c-FLIPS was not affected by the tail deletion, the antiapoptotic activity and ubiquitin-mediated degradation of c-FLIPS are functionally and structurally independent processes. The presence of a small destabilizing sequence in c-FLIPS constitutes an important determinant of c-FLIPS/c-FLIPL ratios by allowing differential degradation of c-FLIP isoforms. The conformation-based predisposition of c-FLIPS to ubiquitin-mediated degradation introduces a novel concept to the regulation of the death-inducing signaling complex.
1 February 2003 in Molecular and Cellular Biology
Regulation of the apoptotic threshold is of great importance in the homeostasis of both differentiating and fully developed organ systems. Triggering differentiation has been employed as a strategy to inhibit cell proliferation and accelerate apoptosis in malignant cells, in which the apoptotic threshold is often characteristically elevated. To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied death receptor responses during erythroid differentiation of K562 erythroleukemia cells, which normally are highly resistant to tumor necrosis factor (TNF) alpha-, FasL-, and TRAIL-induced apoptosis. However, upon hemin-mediated erythroid differentiation, K562 cells specifically lost their resistance to TNF-related apoptosis-inducing ligand (TRAIL), which efficiently killed the differentiating cells independently of mitochondrial apoptotic signaling. Concomitantly with the increased sensitivity, the expression of both c-FLIP splicing variants, c-FLIP(L) and c-FLIP(S), was downregulated, resulting in an altered caspase 8 recruitment and cleavage in the death-inducing signaling complex (DISC). Stable overexpression of both c-FLIP(L) and c-FLIP(S) rescued the cells from TRAIL-mediated apoptosis with isoform-specific effects on DISC-recruited caspase 8. Our results show that c-FLIP(L) and c-FLIP(S) potently control TRAIL responses, both by distinct regulatory features, and further imply that the differentiation state of malignant cells determines their sensitivity to death receptor signals.